EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endoscopic Sampling Impact on PICaSSO Histologic Remission Index Scoring in Ulcerative Colitis

Mackenzie E. C. Imhoff, Genevieve Parecki, Rachel Bowen, Timothy R. Holzer, Xiaoxian Zhao, Eric D. Hsi, Richard E. Moses, Xianyong Gui, Darryl Ballard, Via Abiera, Haiyan Lu, Alexander Koch und 3 weitere

JCC Plus · 2026

DOI: 10.1002/jcc5.70008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCC Plus, 2026. Verfasst von Mackenzie E. C. Imhoff und 14 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite histologic remission (HR) being important in management of ulcerative colitis, the impact of endoscopic sampling on newer scoring systems remains uncertain. This study examines the outcome of applying PICaSSO Histologic Remission Index (PHRI) scoring on biopsies collected during routine clinical care and investigates the impact of endoscopic sampling variation on PHRI scoring and HR status.

Methods

A retrospective survey of UC endoscopic biopsies ( N = 128, 559 bites, 1–13 bites/biopsy) was evaluated using standard H&E stain and myeloperoxidase (MPO) immunohistochemistry to aid neutrophil identification. Convolutional neural networks (CNN), trained on colonic tissue architecture and cytomorphology features, were deployed alongside pathologist interpretations. In silico modeling of bite‐derived virtual biopsies ( N = 19,760) was investigated to determine the impact of sampling variation on PHRI scores and compared with ground truth clinical samples.

Results

PHRI MPO scoring displayed improved sensitivity and specificity for identifying neutrophils, compared with PHRI H&E . CNN‐derived PHRI scoring was most accurate for chronic active and chronic active with ulceration categories, with greatest variability observed in chronic inactive biopsies. Virtual patient biopsies comprised of < 5 endoscopic bites were impacted most by sampling permutations. Limited variability in PHRI scores was observed in samples consisting of ≥ 5 bites.

Conclusions

HR status (PHRI = 0) determination was slightly impacted by sampling. Biopsies consisting of < 5 endoscopic bites exhibited the most variability. Conservative sampling of 5–7 endoscopic bites may produce more accurate assessments of microscopic heterogeneity in clinical studies employing quantitative histologic measurements to assess disease activity and remission. Additionally, incorporating MPO increased the sensitivity and specificity of detecting active inflammation for PHRI scoring.

Zitieren

APA

Imhoff, M. E. C., Parecki, G., Bowen, R., Holzer, T. R., Zhao, X., Hsi, E. D., Moses, R. E., Gui, X., Ballard, D., Abiera, V., Lu, H., Koch, A., Sticker, A., Credille, K. M., & Gruver, A. M. (2026). Endoscopic Sampling Impact on PICaSSO Histologic Remission Index Scoring in Ulcerative Colitis. JCC Plus. https://doi.org/10.1002/jcc5.70008

Vancouver

Imhoff MEC, Parecki G, Bowen R, Holzer TR, Zhao X, Hsi ED, et al. Endoscopic Sampling Impact on PICaSSO Histologic Remission Index Scoring in Ulcerative Colitis. JCC Plus. 2026. doi:10.1002/jcc5.70008

BibTeX
@article{Imhoff2026,
  author = {Imhoff, Mackenzie E. C. and Parecki, Genevieve and Bowen, Rachel and Holzer, Timothy R. and Zhao, Xiaoxian and Hsi, Eric D. and Moses, Richard E. and Gui, Xianyong and Ballard, Darryl and Abiera, Via and Lu, Haiyan and Koch, Alexander and Sticker, Adriaan and Credille, Kelly M. and Gruver, Aaron M.},
  title = {Endoscopic Sampling Impact on PICaSSO Histologic Remission Index Scoring in Ulcerative Colitis},
  journal = {JCC Plus},
  year = {2026},
  doi = {10.1002/jcc5.70008}
}
Kostenlos starten →